Table 1.

HiBalance program design differences between the efficacy and effectiveness-implementation stages

Program feature	HiBalance-RCT (Efficacy phase)	HiBalance-clinical setting (Effectiveness/Implementation phase)
Inclusion criteria	Idiopathic Parkinson’s disease	Idiopathic Parkinson’s disease
	Hoehn & Yahr score of 2 or 3	Hoehn & Yahr score of 2 or 3
	Able to walk independently indoors without an aid	Able to walk independently indoors without an aid
	Mini-Mental State examination score > 24 points	Cognitively capable of following instructions in a group setting
	Age ≥60 years	All Ages
Core components	Individually adapted, highly challenging and progressive balance training in 3 blocks with progressively integrated dual-task training	Individually adapted, highly challenging and progressive balance training in 3 blocks with progressively integrated dual-task training
Dose	30 h of group training (3 x 1 h sessions/week x 10 weeks)	20 h of group training (2 x 1 h sessions/week x 10 weeks) 10 h home exercise program (1 h/week x 10 weeks)
Providers	Physical therapist PhD students (site responsible) and clinicians	Physical therapist clinicians
Sites	2 sites, one university hospital	4–6 clinical sites/primary care clinics
Outcome evaluation
Performance-based
Balance performance	Mini-BESTest score	Mini-BESTest score
	Modified figure of eight test
Physical activity level	Steps per day measured by accelerometer	Steps per day measured by accelerometer
Self-reported
Fear of falling/balance confidence	Falls Efficacy Scale-International (FES-I) (A measure of concerns about falling)	Activities-specific balance confidence scale (ABC scale) (A measure of balance confidence)
Activities of daily living	Unified Parkinson’s Disease Rating Scale (UPDRS)- ADL component
Self-rated health Walking Evaluation method	SF-36/PDQ-39 PDQ-39 Randomized controlled trial	EQ-5D-3 L Walking impact scale (Walk 12G) Non-randomized controlled design